Sarcoidosis in A. C. Milan (1899)?

Authors

  • Georgi Tchernev Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia; ”Onkoderma” - Policlinic for Dermatology and Dermatologic Surgery, Sofia
  • Torello Lotti University G. Marconi of Rome - Dermatology and Venereology, Rome
  • Uwe Wollina Städtisches Klinikum Dresden - Department of Dermatology and Allergology, Dresden, Sachsen
  • José Carlos Cardoso Dermatology Department, Coimbra Hospital and University Center, Praceta Mota Pinto, Coimbra
  • Lyubomira Viktor Popova Saint Kliment Ohridski University, Sofia
  • Georgi Konstantinov Maximov Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia
  • Ilia Lozev Medical Institute of Ministry of Interior, Department of General, Vascular and Abdominal Surgery, General Skobelev 79, 1606 Sofia
  • Ivan Terziev Medical Institute of Ministry of Interior, Department of General, Vascular and Abdominal Surgery, General Skobelev 79, 1606 Sofia

DOI:

https://doi.org/10.3889/oamjms.2018.049

Keywords:

Sarcoidosis, Sarcoid - type reaction, Cutaneous granuloma, Molecular mimicry, Tattoo, Exogenous pigment

Abstract

The pathogenesis, diagnosis and therapy of sarcoidosis as an autonomous disease are subjects of spirited discussions, which haven’t found definitive conclusion yet. Distinguishing between sarcoidosis and sarcoid-like reactions (sarcoid - type granulomas) is not currently a medical “gold standard†and is not implemented in clinical practice. This leads to 1) misinterpretation of numerous available data; 2) difficulty in the interpretation of other unverified data, which is often followed by 3) inappropriate or inadequate therapeutic approach. Similarly to many other diseases, in sarcoidosis and sarcoid - types of reactions the concept of personalised approach and therapy should also be introduced. This methodology of clinical guidance is difficult, complex and not always achievable in the current medical status and relations (doctor-patient relationship; financial factor; time factor). It is appropriate to note that in some cases the guidelines or the so-called standards are neglected or not possible to put into practice with the aim of better therapeutic practices and strategies, as well as the achievement of optimal final clinical results (especially in patients with sarcoid granulomas). The sarcoid granuloma, even when it is sterile, should not be considered as the equivalent of sarcoidosis, i.e., sarcoidosis as an autonomous disease. Sure enough, exactly because of this fact, the personalised approach should not be an exception, but it has to gradually become a rule in medical practice. When clinical decisions are conformed to some of the latest modern concepts, officialised in the international databases, often the achieved results can be much better.

We present a patient with a tattoo of AC Milan (1899) on his right arm, who subsequently developed localised sterile sarcoid granulomas in the area of the tattoo. Later the process became generalised on his whole body’s skin, lungs and lymph nodes. It is unclear for the moment whether this condition should be interpreted as sarcoidosis as an autonomous disease or, instead, as a sarcoidal type of reaction with subsequent generalisation due to cross-reactivity against antigens present in other tissues with similarities to the exogenous pigments. Following the modern concepts regarding the pathogenesis of these two conditions, we introduced, in this case, an innovative, non-standard approach: 1) systemic and local immunosuppressive therapy, combined with 2) recommеndation for immediate surgical excision of the tattoo to remove the possible trigger of molecular and antigen mimicry.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

James DG. A clinicopathological classification of granulomatous disorders. Postgraduate Medical Journal. 2000; 76:457-465. https://doi.org/10.1136/pmj.76.898.457 PMid:10908370 PMCid:PMC1741697

Tchernev G, Chokoeva AA, Schiavone C, D Erme AM, Tana C, Darling M, Kaley J, Gianfaldoni S, Wollina U, Lotti T, Patterson JW. Sarcoidosis exclusion criteria: the "simple truth" for a "complicated diagnosis". J Biol Regul Homeost Agents. 2015; 29(1 Suppl):5-9. PMid:26016958

Tchernev G, Tana C, Schiavone C, Cardoso JC, Ananiev J, Wollina U. Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin? Wien Med Wochenschr. 2014; 164(13-14):247-59. https://doi.org/10.1007/s10354-014-0269-x PMid:24664574

Mukhopadhyay S, Gal AA. Granulomatous Lung Disease: An Approach to the Differential Diagnosis. Archives of Pathology & Laboratory Medicine. 2010; 134(5): 667-690. PMid:20441499

Mitchell DN, Scadding JG, Heard BE, Hinson KF. Sarcoidosis: histopathological definition and clinical diagnosis. Journal of Clinical Pathology. 1977; 30(5):395-408. https://doi.org/10.1136/jcp.30.5.395 PMid:325017 PMCid:PMC476430

Bonham CA, Strek ME, Patterson KC. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. Current opinion in pulmonary medicine. 2016; 22(5):484-491. https://doi.org/10.1097/MCP.0000000000000301 PMid:27379967 PMCid:PMC5532138

Tchernev G, Cardoso JC, Chokoeva AA, Verma SB, Tana C, Ananiev J, Gulubova M, Philipov S, Kanazawa N, Nenoff P, Lotti T, Wollina U. The "mystery" of cutaneous sarcoidosis: facts and controversies. Int J Immunopathol Pharmacol. 2014; 27(3):321-30. https://doi.org/10.1177/039463201402700302 PMid:25280023

Brownell I, Ramírez-Valle F, Sanchez M, Prystowsky S. Evidence for Mycobacteria in Sarcoidosis. American Journal of Respiratory Cell and Molecular Biology. 2011; 45(5):899-905. https://doi.org/10.1165/rcmb.2010-0433TR PMid:21659662 PMCid:PMC3361363

Moravvej H, Vesal P, Abolhasani E, Nahidi S, Mahboudi F. Comorbidity of Leishmania Major with Cutaneous Sarcoidosis. Indian Journal of Dermatology. 2014; 59(3):316. https://doi.org/10.4103/0019-5154.131453 PMid:24891680 PMCid:PMC4037970

Pierce TB, Margolis M, Razzuk MA. Sarcoidosis: still a mystery? Proceedings (Baylor University Medical Center). 2001; 14(1):8-12. https://doi.org/10.1080/08998280.2001.11927724

Newman KL, Newman LS. Occupational Causes of Sarcoidosis. Current opinion in allergy and clinical immunology. 2012; 12(2):145-150. https://doi.org/10.1097/ACI.0b013e3283515173 PMid:22314258 PMCid:PMC4196683

Williams WJ, Williams D. "Residual bodies" in sarcoid and sarcoid-like granulomas. J Clin Pathol. 1967; 20(4):574-7. https://doi.org/10.1136/jcp.20.4.574

Balasubramaniam SC, Salomão DR, Davies JB, Ramsay RC, Habermann TM, Chow GK,Boorjian SA, Pulido JS. Paraneoplastic sarcoid-like reactions and the eye. Retina. 2015; 35(4):789-97. https://doi.org/10.1097/IAE.0000000000000429 PMid:25526097

Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007; 25(3):326-33. https://doi.org/10.1016/j.clindermatol.2007.03.010 PMid:17560310

Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol. 2005; 296:1-17. https://doi.org/10.1007/3-540-30791-5_1

Beegle SH, Barba K, Gobunsuy R, Judson MA. Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Design, Development and Therapy. 2013; 7:325-338. PMid:23596348 PMCid:PMC3627473

Penn I, Starzl TE. The Effect of Immunosuppression on Cancer. Proceedings National Cancer Conference. 1972; 7:425-436. PMid:4587653 PMCid:PMC3079479

Orlicka K, Barnes E, Culver EL. Prevention of infection caused by immunosuppressive drugs in gastroenterology. Therapeutic Advances in Chronic Disease. 2013; 4(4):167-185. https://doi.org/10.1177/2040622313485275 PMid:23819020 PMCid:PMC3697844

Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau Syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatric Rheumatology Online Journal. 2014; 12:33. https://doi.org/10.1186/1546-0096-12-33 PMid:25136265 PMCid:PMC4136643

Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009; 60(1):242-50. https://doi.org/10.1002/art.24134 PMid:19116920

Celada LJ, Hawkins C, Drake WP. The etiologic role of infectious antigens in sarcoidosis pathogenesis. Clinics in chest medicine. 2015; 36(4):561-568. https://doi.org/10.1016/j.ccm.2015.08.001 PMid:26593133 PMCid:PMC4660257

Robinson LA, Smith P, SenGupta DJ, Prentice JL, Sandin RL. Molecular analysis of sarcoidosis lymph nodes for microorganisms: a case–control study with clinical correlates. BMJ Open. 2013; 3(12):e004065. https://doi.org/10.1136/bmjopen-2013-004065 PMid:24366580 PMCid:PMC3884606

Published

2018-01-13

How to Cite

1.
Tchernev G, Lotti T, Wollina U, Cardoso JC, Popova LV, Maximov GK, Lozev I, Terziev I. Sarcoidosis in A. C. Milan (1899)?. Open Access Maced J Med Sci [Internet]. 2018 Jan. 13 [cited 2021 Apr. 11];6(1):99-102. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.049

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>